Surveying the Landscape: Annual Burden of RSV in Older Adults

11/21/23 • 12 min

In this accredited podcast episode, Dr Mary Bridgeman discusses the most important things for pharmacists across all settings to know about RSV infections in patients 60 years of age or older, including:

Incidence and prevalence of RSV in older adults, including hospitalization, mortality, epidemiology
Seasonality
Clinical manifestations
Risk factors for severe outcomes
Vulnerable groups and comorbidities

Presenter:

Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Other program activities:

Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role
https://bit.ly/49GUv1g

Link to CME: Claim Credit – https://bit.ly/47GtNnK

[After selecting the “Continue to Post Test” button:]

To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select the best answer to each question. When you have completed all the questions, press the "Continue" button at the bottom.

Incidence and prevalence of RSV in older adults, including hospitalization, mortality, epidemiology
Seasonality
Clinical manifestations
Risk factors for severe outcomes
Vulnerable groups and comorbidities

Presenter:

Other program activities:

Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role
https://bit.ly/49GUv1g

Link to CME: Claim Credit – https://bit.ly/47GtNnK

[After selecting the “Continue to Post Test” button:]

Previous Episode

Q&A on HIV PrEP: Episode 5 on Transgender Individuals and Racial and Ethnic Minority Men Who Have Sex With Men Part 2

In this episode, Aniruddha (Anu) Hazra, MD, and Ofole Mgbako, MD, discuss key considerations for PrEP uptake in transgender individuals and racial and ethnic minority men who have sex with men, including:

Data on drug–drug interactions between PrEP options and gender-affirming hormone therapy
Contributing factors to inequities in PrEP uptake for Black and Latino individuals
Data on FTC/TAF PrEP for transgender individuals
How to decide whether to do an oral lead-in before starting injectable cabotegravir PrEP
Time to effectiveness after starting PrEP
PrEP resources available for transgender communities, especially regarding stigma
Integration of PrEP with gender-affirming hormone therapy
Strategies to increase PrEP uptake, specifically in the south
Counseling patients on drug–drug interactions, adverse events, and transmission risk when starting PrEP
Involving PrEP navigators in the care of people receiving PrEP
Supporting PrEP adherence and retention in care
The use of DoxyPEP in transgender individuals receiving PrEP

Faculty

Aniruddha (Anu) Hazra, MD
Assistant Professor, Section of Infectious Disease and Global Health
Director, Infectious Diseases Fellowship Program
Medical Director, UCM Sexual Wellness Clinic
Director of STI Services, Chicago Center of HIV Elimination
Department of Medicine
University of Chicago
Chicago, Illinois

Ofole Mgbako, MD
Assistant Professor of Medicine and Population Health
Section Chief of Infectious Disease
Bellevue Hospital
Clinical Pillar Lead, NYU Institute for Excellence in Health Equity
NYU Grossman School of Medicine
NYU Langone Health
New York, New York

Link to full program: https://bit.ly/3PZGYdR

Next Episode

Light on the Horizon: Developments in RSV Vaccines

In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman discuss the latest practical strategies for preventing RSV infection in older adults, including:

Role of basic public health precautions
Available and emerging vaccines
Mechanisms of action, therapeutic targets, and pharmacology
Efficacy and safety data
FDA approval status and ACIP recommendations

Presenters:
Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Christina M. Madison, PharmD, FCCP, AAHIVP
Clinical Pharmacist
Founder and CEO, The Public Health Pharmacist, PLLC
Adjunct Associate Professor of Pharmacy Practice
Roseman University of Health Sciences
College of Pharmacy
Henderson, Nevada

Other program activities:

• Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role